Security Notice: Please be aware of impersonation attempts using our company name
Legitimate communications from Ascent Research will only come from official @ascentresearch.com email addresses.
Quick Order Cart

Cat. No. ARG43098

CCDC88C Knockout HEK293T Polyclonal Cells

  • Product Type:

    Polyclonal Cell Population

  • Species:

    Homo sapiens (Human)

  • Tissue Source:

    Kidney

CCDC88C Knockout HEK293T Polyclonal Cells are a CRISPR/Cas9-mediated polyclonal knockout population derived from HEK293T human embryonic kidney cells. Disruption of CCDC88C (Daple) removes a scaffold protein that couples Dishevelled (DVL1/2/3) to the Rho GTPases RhoA and Rac1, impeding non-canonical Wnt/planar cell polarity signaling. This loss-of-function model enables investigation of cytoskeletal dynamics, directional cell migration, and invasion in an easily transfectable host. Compatible assays include Rho activation pull-downs, co-immunoprecipitation with DVL, wound healing, transwell invasion, and immunofluorescence for F-actin, making these cells valuable for cancer biology, neural development, and Wnt pathway research.

Inquire Now

In stock

Ships next business day


Ask a Question

Shipping Info:

Cryopreserved in vials and shipped on dry ice


Disclaimer:

For Research Use Only

  • Characteristics

    Host Cell

    HEK293T

    Sex of Donor

    Female

    Age

    Fetus

    Derived From Site

    Fetal kidney

    Gene Name

    CCDC88C

    Gene Identifier

    NCBI Gene ID 440193

    Growth Mode

    Adherent

    Storage

    Liquid nitrogen (LN2)

  • Culture Conditions

    Growth medium

    DMEM

    Supplement(s)

    10% Fetal Bovine Serum, 1% Penicillin-Streptomycin Solution

    Temperature

    37°C

    Atmosphere

    5% CO₂

  • Quality Control

    Sterility testing

    The bacterial, yeast, and fungi are not detected in these cells by daily monitor.

    Mycoplasma testing

    Negative for mycoplasma through PCR analysis

  • Disclaimer

    Intended Use

    This product is intended for laboratory in vitro use only. lt is not intended for diagnostic, therapeutic, or clinical applications.

    Disclaimer

    Ascent Research endeavors to provide accurate and up-to-date product information. However, no warranties or representations are made regarding its completeness or reliability. References to scientific literature and patents are for informational purposes only, and the customer assumes sole responsibility for verifying their accuracy.

    By accepting this product, the customer acknowledges and agrees to assume all risks associated with its receipt, handling, storage, disposal, and use, including compliance with all applicable safety and environmental regulations and precautions. Relevant laws, regulations, and ethical guidelines must be followed in conducting any research, modifications, or derivatives derived from this product.

    This product is provided "AS IS", and except as expressly stated herein, Ascent Research disclaims all other warranties, express or implied. Under no circumstances shall Ascent Research, its affiliates, or representatives be liable for indirect, incidental, consequential, or punitive damages arising from the use of this material. While Ascent Research employs rigorous quality control measures, we shall not be held responsible for damages resulting from misidentification or misinterpretation of the provided materials.

Description

CCDC88C Knockout HEK293T Polyclonal Cells are a polyclonal knockout cell population derived from HEK293T cells, generated through CRISPR/Cas9-mediated disruption of the CCDC88C gene. This pooled knockout model provides a heterogeneous collection of edited cells, each carrying distinct mutations at the target locus, reflecting the spectrum of genomic modifications induced by non-homologous end joining repair. As a polyclonal knockout product, it is suited for population-level assays where bulk loss-of-function effects are interrogated, avoiding potential clonal artifacts while maintaining the genetic diversity inherent in the edited pool.

The parental HEK293T cell line is a human embryonic kidney epithelial derivative that constitutively expresses the SV40 large T antigen, a feature that enables high-copy episomal replication of plasmids containing the SV40 origin of replication. This property, together with its exceptional transfectability, makes HEK293T a preferred host for recombinant protein expression, lentivirus production, and functional genomics experiments. The cell line retains active Wnt, MAP kinase, and Rho GTPase pathways, offering a versatile background for genetic perturbation studies.

CCDC88C, also designated Daple, encodes a multidomain scaffolding protein that occupies a central node in non-canonical Wnt/planar cell polarity (PCP) signaling. Mechanistically, it forms a complex with Dishevelled (DVL1/2/3) and the core PCP components VANGL1/2 and PRICKLE1, and subsequently couples these proximal signaling events to the activation of RhoA, Rac1, and JNK. Through this coupling, CCDC88C translates extracellular WNT5A and WNT11 signals, received by Frizzled receptors, into dynamic rearrangements of the actin cytoskeleton. This pathway is crucial for directed cell migration, establishment of epithelial polarity, and morphogenetic processes such as neural tube closure.

Within the HEK293T context, the CCDC88C knockout polyclonal cells permit dissection of Rho GTPase-driven signaling events in a model system that is both readily transfectable and well-characterized for Wnt pathway studies. Because HEK293T cells do not exhibit complex epithelial polarization programs, the phenotype attributable to Daple loss can be attributed more directly to cytoskeletal and migration defects rather than to developmental polarity cues. Researchers can rescue the knockout phenotype by expressing wild-type or mutant CCDC88C constructs, enabling structure-function analyses. Moreover, the cell line??s robust growth and compatibility with high-content imaging platforms facilitate scalable screening campaigns.

Key experimental applications include quantitative assessment of cell migration using wound healing and transwell invasion assays, visualization of F-actin architecture via immunofluorescence, and biochemical determination of RhoA and Rac1 activation status through pull-down approaches. Co-immunoprecipitation experiments can confirm the disruption of the CCDC88C-Dishevelled interaction, while phospho-specific western blotting for JNK provides a readout of pathway activity. These applications are central to investigations of cancer cell dissemination, neural tube defect etiology, and Wnt/PCP signal transduction. For further details or ordering inquiries, please contact Ascent Research.

Reset Password

    Reach Us Questions? Click Me Here!

    Fill out the form below and a member of our team will contact you shortly!

    *Required field



      Reach Us

      Fill out the form below and a member of our team will contact you shortly!

      *Required field

      Product Inquiry (Optional)